Form 8-K - Current report:
SEC Accession No. 0001213900-14-007315
Filing Date
2014-10-16
Accepted
2014-10-16 08:06:03
Documents
2
Period of Report
2014-10-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k101614_relmada.htm 8-K 14374
2 RELMADA THERAPEUTICS, INC. REINFORCES BALANCE SHEET WITH $XX MILLION FROM EXERCI f8k101614ex99i_relmada.htm EX-99.1 10492
  Complete submission text file 0001213900-14-007315.txt   26048
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 333-184881 | Film No.: 141158826
SIC: 2834 Pharmaceutical Preparations